4-Phenylthiazole derivatives inhibit IL-6 secretion in osteoblastic cells and suppress bone weight loss in ovariectomized mice

Bioorganic and Medicinal Chemistry Letters

Volumn 9, Issue 7, 1999, Pages 957-960

  Yamaguchi, Kohji ^a   Yada, Mika ^a   Tsuji, Tomoko ^a   Hatanaka, Yuriko ^a   Goda, Ken ichi ^a   Kobori, Takeo ^a  

^a SAGAMI CHEMICAL RESEARCH CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 4 (4 CHLOROPHENYL) 5 METHYLTHIAZOLE; 4 PHENYLTHIAZOLE; INTERLEUKIN 6; PROTEIN INHIBITOR; SCRC 2941 18; THIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; BONE ATROPHY; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; ESTROGEN ACTIVITY; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOPOROSIS; OVARIECTOMY; REACTION ANALYSIS;

ANIMALS; BONE RESORPTION; INTERLEUKIN-6; MICE; OSTEOBLASTS; OVARIECTOMY; PARATHYROID HORMONE; THIAZOLES;

ANIMALIA;

EID: 0033526107     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(99)00122-5     Document Type: Article

References (16)

1. 1. Akita, S.; Taga, T.; Kishimoto, T. Adv. Immunol. 1993, 54, 1.
2. 2. For example, Tagat, J. R.; Nazareno, D. V.; McCombie, S. W.; Barton, B. E.; Shortall, J.; Jackson, J. Bioorg. Med. Chem. Lett. 1995, 18, 2139, Tagat, J. R.; McCombie, S. W.; Barton, B. E.; Jackson, J.; Shortall, J. Bioorg. Med. Chem. Lett. 1995, 18, 2143.
3. 2. For example, Tagat, J. R.; Nazareno, D. V.; McCombie, S. W.; Barton, B. E.; Shortall, J.; Jackson, J. Bioorg. Med. Chem. Lett. 1995, 18, 2139, Tagat, J. R.; McCombie, S. W.; Barton, B. E.; Jackson, J.; Shortall, J. Bioorg. Med. Chem. Lett. 1995, 18, 2143.
4. 3. Ishimi, Y.; Miyaura, C.; He Jin, C.; Akatsu, T.; Abe, E.; Nakamura, Y.; Yamaguchi, A.; Yoshiki, S.; Matsuda, T.; Hirano, T.; Kishimoto, T.; Suda, T. J. Immunol. 1990, 145, 3297.
5. 4. Jilka, R. L.; Hangoc, G.; Girasole, G.; Passeri, G.; Williams, D. C.; Abrams, J. S.; Boyce, B.; Broxmeyer, H.; Manolagas, S. C. Science 1992, 257, 88.
6. 5. Poli, V.; Balena, R.; Fattori, E.; Markatos, A.; Yamamoto, M.; Tanaka, H.; Ciliberto, G.; Rodan, G. A.; Costantini, F. EMBO J. 1994, 13, 1189.
7. 7 (equation presented)
8. 7. Metzger, J. V. In The Chemistry of Heterocyclic Compounds, Thiazole and Derivatives; John Wiley & Sons: New York, 1978; Vol. 34, Part 1, pp. 165.
9. 11
10. 9. Yada, M.; Yamaguchi, K.; Tsuji, T. Biochem. Biophys. Res. Commun. 1994, 205, 1187.
11. 10. Matsuda, T.; Hirano, T.; Kishimoto, T. Eur. J. Immunol. 1988, 18, 951.
12. 11. Mosmann, T. J. Immunol. Methods 1983, 65, 78.
13. 13,14 Four-week-old female ddY mice were obtained from Japan SLC, Inc. The mice were allowed free access to commercial chow and tap water, and were maintained at 25 ± 0.5 °C. Ovariectomies and sham operations were carried out under ketamine hydrochloride anesthesia. The mice were divided into some groups: sham-operated, ovariectomized control groups and ovariectomized groups treated by test sample. Each group contained 5 mice. The administration of vehicle or test sample dissolved in sterilized water containing 5% DMSO was started from the day after the operations and continued 5 days a week. At 4 weeks after the operations, all the mice had their body weight measured and then killed to retrieve femurs and uterus for measurements. The right femurs were used for the measurement of dry weight (dried at 60 °C for 24 h). Recovery (%) = [(femoral weight of ovariectomized mouse treated by test sample) - (femoral weight of ovariectomized control)] / [(femoral weight of sham-operated control) - (femoral weight of ovariectomized control)] × 100
14. 13. Woo, J.; Yamaguchi, K.; Hayama, T.; Kobori, T.; Sigeizumi, S.; Sugimoto, K.; Kondo, K.; Tsuji, T.; Ohba, Y.; Tagami, K.; Sumitani, K. Eur. J. Pharmacol. 1996, 300, 131.
15. 14. Yamaguchi, K.; Hayama, T.; Makita, T.; Tsuji, T. J. Bone Miner. Metab. 1997, 15, 138.
16. 15. For example, Tuener, R. T.; Riggs, B. L.; Speisberg, T. C. Endcrine Rev. 1994, 15, 275.